Ancient herbal mix put to the test against psoriasis

NCT ID NCT05295979

Completed Disease control Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This phase 2 trial tests whether a Chinese medicine formula called Inflammatory Skin Disease Formula (ISDF) can reduce the severity of plaque psoriasis, a common inflammatory skin condition. Adults with mild to moderate psoriasis will take either ISDF granules or a placebo twice daily for 12 weeks. Researchers will measure changes in skin redness, thickness, and scaling to see if the herbal treatment offers a safer, more affordable alternative to current therapies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: an herbal formula called Inflammatory Skin Disease Formula (ISDF)
What this could lead to: If effective, ISDF could offer a lower-cost, lower-side-effect option for managing psoriasis symptoms.
What could go wrong: This is a small, early-phase trial, so results may not apply broadly. Herbal formulas can vary in potency and may still cause side effects or interact with other medications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PSORIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PSORIASIS

Contacts and locations

Locations

Hong Kong Institute of Integrative Medicine

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.